Seventy-five million American adults have hypertension, and among those diagnosed, approximately half of them have controlled hypertension. 1 The existing literature suggests that incorporating self-management behaviors such as home blood pressure monitoring (HBPM) in behavioral interventions may be an effective approach for improving blood pressure (BP) control. 2 Use of HBPM may also be a cost-effective approach for improving BP control. In a systematic review of HBPM interventions, the estimated cost of an HBPM intervention was $60-$174 per participant; the authors posited that the cost saving was due to correctly diagnosing hypertension, averted cardiovascular disease outcomes, and improved BP control. 3 Clinical studies that promote self-management approaches for reducing BP have been effective in improving the management of hypertension. 4, 5 Halme et al. 6 conducted a randomized, parallel-group study of 269 patients with hypertension to determine if self-monitoring would lead to improved BP control. Participants that self-monitored their BP at home had a lower systolic and diastolic BP than the participants that did not monitor their BP at home. Bosworth et al. 4 conducted a randomized trial to assess the impact of a behavioral intervention combined with HBPM. The intervention and home BP monitoring separately did not improve BP, but combination of the 2 approaches resulted in clinically significant improvements in BP control compared to usual care. A second study by
INTRODUCTION
Seventy-five million American adults have hypertension, and among those diagnosed, approximately half of them have controlled hypertension. 1 The existing literature suggests that incorporating self-management behaviors such as home blood pressure monitoring (HBPM) in behavioral interventions may be an effective approach for improving blood pressure (BP) control. 2 Use of HBPM may also be a cost-effective approach for improving BP control. In a systematic review of HBPM interventions, the estimated cost of an HBPM intervention was $60-$174 per participant; the authors posited that the cost saving was due to correctly diagnosing hypertension, averted cardiovascular disease outcomes, and improved BP control. 3 Clinical studies that promote self-management approaches for reducing BP have been effective in improving the management of hypertension. 4, 5 Halme et al. 6 conducted a randomized, parallel-group study of 269 patients with hypertension to determine if self-monitoring would lead to improved BP control. Participants that self-monitored their BP at home had a lower systolic and diastolic BP than the participants that did not monitor their BP at home. Bosworth et al. 4 conducted a randomized trial to assess the impact of a behavioral intervention combined with HBPM. The intervention and home BP monitoring separately did not improve BP, but combination of the 2 approaches resulted in clinically significant improvements in BP control compared to usual care. A second study by Bosworth et al. 7 compared the delivery of 3 interventions, behavioral self management, home blood pressure monitoring, or a combination. In this study, they found significant improvements in BP compared to usual care in both the behavioral and medication management groups, but not in the combined group. The studies by Halme et al. 6 and Bosworth et al. 4 demonstrate the inconsistency in the findings from studies examining the effectiveness of HBPM.
The differences in the effectiveness of HBPM studies may be attributed to design features that render them less than useful in most clinical settings. For example, many studies do not use ambulatory blood pressure monitoring to assess BP control, which is considered the gold standard. Instead, the studies use approaches such as office BP monitoring and collect BP data at a single time point. 8 We designed a clinical trial to examine the efficacy of HBPM combined with health information in reducing BP and improving medication adherence among patients with hypertension. We hypothesized that participants randomized to the HBPM group would have a lower mean arterial pressure (MAP) and greater adherence to medication at the 3-month follow-up visit.
METHODS

Participant recruitment
The study was advertised on local radio stations, Craigslist, community centers, and churches and Penn State Hershey Medical Center. Ads were placed in local newspapers and radio stations in urban and rural communities in Central Pennsylvania.
General study eligibility criteria
Participants were eligible for participation in the study if they (i) were fluent in English, (ii) were 21-80 years of age, (iii) were diagnosed with hypertension, (iv) were prescribed antihypertensive medications, and (v) had a BP of ≥140/90 or 130/80 mm Hg (for individuals with diabetes). Participants were deemed ineligible for the study if they were pregnant or planning to become pregnant; had a diagnosis of major kidney, heart, or liver failure; diagnosed with cancer recently; or were planning to relocate.
Study design
The 3-month study was designed as a randomized controlled trial and used a 2 × 2 factorial design. Educational sessions were delivered using pamphlets or computer-based modules. Participants were randomized into 1 of 4 groups: group 1 received usual care and educational pamphlets; group 2 received usual care and computer-based education modules; group 3 received home BP monitoring and educational pamphlets; and group 4 received home BP monitoring and computer-based education modules. The primary outcome of the study was the average change in MAP readings from the 24-hour ambulatory blood pressure monitor (ABPM). The secondary outcome was improved adherence to medication, measured using the 4-item Morisky Medication Adherence Scale and prescription refills of antihypertensive medication.
Screening phone call
During the screening phone call, the study details were described to the participant. The research coordinator reviewed the eligibility criteria with the participant to confirm they met the inclusion criteria, with the exception of BP which was measured during the screening visit.
Screening visit
During the screening visit 3 BP readings were taken; if the average of the second and third readings was more than 140/90 or 130/80 mm Hg (for participants with diabetes), the participant was deemed eligible for the study. It should be noted that the present study was conducted before the American College of Cardiology and the American Heart Association updated the high BP guidelines. 9, 10 Informed consent was obtained, and the study staff recorded the participant's hypertension medications and collected demographic data. If the patient was deemed ineligible for the study, they were thanked for their participation and received a $20 gift card. Eligible study participants were fitted with a Spacelabs model 90207-1Q ABPM to wear for 24 hours.
ABPM screening
ABPM was used to determine eligibility as well as the primary study outcomes. The ABPM was programmed to take an estimated total of 72 measurements. If a participant's average BP during the 6 am to 10 pm recordings was 135/80 mm Hg or higher, they met the study inclusion criteria and were asked to return for a baseline visit. If they were ineligible, they were provided with a gift card and thanked for their participation. Of the 293 participants who were eligible at the screening visit, 67 were ineligible due to low average BP.
Randomization visit
Participants were randomized using envelopes prepared by non-study-related staff. Participants in the intervention group were provided with a BP monitor. Participants randomized to the control group received usual care. If the participant was already using a BP monitor they were asked to discontinue using their monitor until the end of the study. Participants were asked to bring their hypertension medications to the follow-up visit and to collect receipts for all hypertension medication refilled during the study.
Intervention
Participants assigned to groups 1 and 3 received 5 educational pamphlets published by the National Heart, Lung and Blood Institute to review during the study visit:
"Take Steps-Prevent High Blood Pressure"; "Watch Your Weight"; "Stay Active and Feel Better"; "Cut Down on FatNot on Taste"; "Cut Down on Salt and Sodium." Participants assigned to groups 2 and 4 completed computer-based educational modules, containing information identical to the National Heart, Lung and Blood Institute pamphlets. Groups 3 and 4 (the intervention group) were provided with a home BP monitor and instructed on the procedure for taking their BP. The HBPM group participants were instructed to use the monitor once in the morning and evening, 3 days of the week. Participants were instructed to store each reading in the monitor's memory and manually on the provided logs.
Follow-up visit at 3 months
Individuals assigned to the HBPM group were asked to bring the BP monitor to the visit. Study participants in the HBPM group were permitted to keep their BP monitor, and participants in the usual care group received a BP monitor for participating. Study staff completed the medication log and participants received a $15 gift card for refilling their prescriptions. All participants were fitted with the ABPM to wear for a 24-hour period following the study visit. The participants were provided with a self-addressed, prepaid mailer to return the monitor and cuff as after the 24-hour period. Participants received a $50 gift card for completing their follow-up visit.
Adverse events
The research staff notified participants of high readings while they were wearing the ABPM. Participants were encouraged to contact their primary care provider if their BP exceeded 165/95 mm Hg during the study. If a participant's BP reading was higher than 180/110 mm Hg, the research staff contacted the General Clinical Research Center's nurse and requested a second reading. If the participant's BP was still above 180/110 mm Hg, they were directed to the emergency department. Seven reported adverse events were due to discomfort while wearing the ambulatory BP monitor and were reported to the institutional review board and Data Safety Monitoring Board.
Outcome BP data were obtained from systolic, diastolic, and MAP readings from the 24-hour ABPM at screening and 3 months. The participant's antihypertensive medications and self-reported adherence were collected at screening and during the 3-month follow-up visit. Medication adherence was measured using the Morisky Medication Adherence Scale. 11 The Morisky Medication Adherence Scale has an internal consistency of Cronbach's α of >0.70.
Demographic and health outcomes data
Demographic and health outcomes data such as high cholesterol, stroke, depression, and heart disease were collected. The SF-12 survey was used to collect data on physical and mental health status. 12 The SF-12 has high reliability in older adults as evidenced by the α of >0.86. 13 We used the Center for Epidemiologic Studies Depression Scale to measure depression. 14 The Center for Epidemiologic Studies Depression Scale has been indicated as a reliable measure of assessing depressive symptoms, with a high internal consistency of α of >0.73-α of >0.90. [14] [15] [16] 
Statistical analysis
All statistical analyses were performed using SAS, version 9.3 (SAS Institute, Cary, NC). Categorical variables were summarized with frequencies and percentages whereas continuous variables were summarized with means and SDs. For demographic variables and characteristics measured at screening only, we compared study groups using a 2-sample t test with means for continuous variables and using a chi-square test with percentages for categorical variables. An exact test was used when cell counts were too small for the chi-square test to be valid. We calculated the change from screening to follow-up by subtracting the initial measurement from the measurement at follow-up. Comparisons within and between treatment groups regarding the mean change from screening or randomization to follow-up for each outcome were made using a linear fixed-effects model adjusted for the initial screening measurement and gender, which showed a significant association with the study groups. Bonferroni's correction for multiple comparisons was used to adjust for the 2 within-study group comparisons. A Spearman correlation was used to quantify the correlation between change from screening to follow-up in 24-hour MAP and the total number of BP readings. The study was reviewed and approved by the institutional review board of the Penn State Hershey Medical Center.
RESULTS
Two hundred thirteen participants were randomized for the study. Of the eligible participants, 203 (95%) participants completed the study. A flow chart describing the process for screening and recruitment is included in the supplemental data (See Supplementary File A) . Ambulatory blood pressure data (≥50% of the 24-hour readings) at follow-up were collected from 96% (n = 194) of the participants that completed the study. Nine participants were withdrawn because they did not wear the monitor for the 24-hour period or wished to discontinue their participation because of discomfort from the BP monitor. Table 1 describes the characteristics of the study participants. The HBPM and usual care groups were similar for age, race, ethnicity, marital status, education, employment, income, and body mass index. The 2 groups were also similar in terms of their medical history. The control group had a higher percentage of women (intervention: 34.9%; control: 48.6%; P = 0.043), and the screening 24-hour ambulatory MAP was higher in the intervention group (intervention: 108.0; control: 104.8; P = 0.033).
Participants took an average of 56 readings of 72 recommended (78%). Figure 1 presents the change in 24-hour ambulatory MAP and the average weekly HBPM readings by intervention participants. We did not detect a statistically significant correlation between the weekly number of HBPM readings and 24-hour MAP from screening to follow-up (r = 0.03, P = 0.750). We explored daytime (P = 0.301) and nocturnal (P = 0.402) BP in the intervention and control group, and did not find a statistically significant difference between the 2 groups. Table 2 presents mean 24-hour ABPM measurements at screening and 3-month follow-up. The intervention and control groups each had statistically significant reductions in ABPM measurements from screening to follow-up. We did not detect a statistically significant difference between groups when comparing the mean change of ABPM variables. The average reduction in 24-hour MAP between screening and follow-up was −5.1 for the intervention group and −4.3 for the control group (P = 0.561). Similar results were found for 24-hour ABPM diastolic (P = 0.995) and 24-hour ABPM systolic (P = 0.113) readings. Table 3 presents the secondary outcome measures, such as total BP medications, medication adherence, and the mean change between groups. We did not detect statistically significant differences in BP medication use from randomization to follow-up (P = 0.988) in the intervention group. We detected a statistically significant difference between randomization and follow-up for the control group for self-reported adherence (P < 0.001), indicating greater medication adherence at follow-up than at randomization. However, there was no significant difference between study groups based on the mean change (P = 0.068).
We ran a subgroup analysis by gender to assess if there were differences. There was a more significant reduction in the intervention group vs. the control group in BP outcomes between the screening and follow-up visit for females than for males. The difference was only for systolic BP (Females: −8.25 in the intervention group vs. −2.49 in the control group, P = 0.040; Males: −5.52 in the intervention group vs. −5.08 in the control group, Abbreviation: BP, blood pressure; CHD, coronary heart disease; MI, myocardial infarction. *P values from 2-sample t test or from chi-square test; exact test used when needed P = 0.844) and not diastolic or MAP. We did not detect any differences in adherence or BP medications when analyzed by gender.
DISCUSSION
We conducted a 3-month randomized controlled trial to assess the efficacy of HBPM in improving uncontrolled BP and medication adherence among adults in central Pennsylvania. Within our study sample, HBPM did not lead to significant improvements in BP control or medication adherence. There may have been a number of factors that contributed to our inability to detect an effect. First, the data were not shared with a provider until the end of the study; however, HBPM data may be useful to physicians as they often reflect the patient's actual BP more accurately than office BP measurements. 17 The American Heart Association suggest data obtained from HBPM may help providers decide which treatments work best for their patient. 18 The present study focused on measurement, but measurement and lifestyle changes may not lead to a significant reduction in BP and having a provider make adjustments to medication may be required. Second, we provided health information through pamphlets or a computer-based program which contained similar content; the only difference was the mode of delivery. Perhaps a more frequent educational intervention would have a greater impact on BP and medication adherence. Hacihasanoğlu et al. 19 conducted an HBPM study with educational sessions. The intervention consisted of 6 educational sessions for 45 minutes each. The groups that participated in the educational intervention had a lower systolic and diastolic BP than the control group that only received HBPM. Last, our intervention was brief, 3 months; perhaps we would have seen more significant changes in BP with a longer intervention period.
The findings of this study were consistent with those of Midanik et al. The authors conducted an HBPM study of 204 patients. The research team was unable to detect significant differences between groups based on their use of HBPM. 20 Conversely, Fuchs et al. 21 performed a study using 24-hour ambulatory data to determine the efficacy of HBPM and observed a significant difference in BP between groups during the 60-day intervention. Uhlig et al. 22 , who conducted a systematic review and meta-analysis of 52 studies, indicated that HBPM was associated with lower BP compared to usual care. Their findings also indicate that additional support (medication management, behavioral interventions, and home visits) was linked with greater reductions in BP compared to usual care. 22 To the best of our knowledge, this study it is the most recent assessment of the effectiveness of homebased monitoring and using ambulatory blood pressure. Our findings provide greater insights into the potential usefulness of HBPM. The reductions we saw in medication adherence may have been due to the control group adjusting their behavior based on being in the study. The study was also limited in that we did not track how many participants contacted their physicians about elevated BP readings, and we did not collect data on how many participants had home BP monitors and if they were using them during the study. Last, it is possible that the changes found between groups may have been a result of individuals with lower BP having lower changes in BP.
Our findings highlight the importance of using HBPM data in a clinically meaningful way. Coupling HBPM with a Mean change estimates and P values from a linear fixed effects model adjusted for screening measure and gender; change = follow-up -screening. more robust intervention for promoting behavioral change may contribute to greater reductions in BP. This study also provides insights into the potential utility and effectiveness of HBPM and may be useful in developing future interventions that use HBPM to improve health outcomes.
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Supplementary data are available at American Journal of Hypertension online.
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